Work

Phase 1 study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC): Correlation of tumor and serum biomarker data with disease control.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.4095

Authors: Matteo Simonelli, Crystal Shereen Denlinger, Laura Williams Goff, Cristina Noberasco, Tae-You Kim, Melanie B. Thomas, Filippo G. De Braud, Paolo A. Zucali, Armando Santoro, Patricia A English, Corrado Gallo-Stampino, Erjian Wang, Marina Carpentieri, James Andrew Williams

Institutions: Humanitas University, Fox Chase Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, European Institute of Oncology, Seoul National University, Seoul National University Hospital, Medical University of South Carolina, Pfizer (United States)

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2908236993

Cites:

Cited by: 2

Related to: 10